Srinivas Cheruku

Person

Bangalore, IN

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,145,927
- Issue date Nov 19, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,059,420
- Issue date Aug 13, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted amide compounds useful as farnesoid X receptor modulators
- Patent number 12,030,835
- Issue date Jul 9, 2024
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 11,713,312
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 11,254,663
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 11,253,525
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,961,229
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,954,225
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bridged bicyclic compounds as farnesoid X receptor modulators
- Patent number 10,730,863
- Issue date Aug 4, 2020
- Bristol-Myers Squibb Company
- David S. Yoon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,501,451
- Issue date Dec 10, 2019
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
- Patent number 10,399,932
- Issue date Sep 3, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,344,020
- Issue date Jul 9, 2019
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IDO inhibitors
- Patent number 10,167,254
- Issue date Jan 1, 2019
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IDO inhibitors
- Patent number 9,790,169
- Issue date Oct 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20230109670
- Publication date Apr 6, 2023
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220213026
- Publication date Jul 7, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220162201
- Publication date May 26, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220135550
- Publication date May 5, 2022
- Bristol-Myers Squibb Company
- Dean A. WACKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220081430
- Publication date Mar 17, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210355113
- Publication date Nov 18, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20210299126
- Publication date Sep 30, 2021
- Bristol-Myers Squibb Company
- James Aaron BALOG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20210261535
- Publication date Aug 26, 2021
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20200115370
- Publication date Apr 16, 2020
- Bristol-Myers Squibb Company
- Imadul Islam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20200071304
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
- Publication number 20200069695
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20190127358
- Publication date May 2, 2019
- Bristol-Myers Squibb Company
- David S. Yoon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20180312491
- Publication date Nov 1, 2018
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20180312495
- Publication date Nov 1, 2018
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER
- Publication number 20180079712
- Publication date Mar 22, 2018
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IDO INHIBITORS
- Publication number 20170231999
- Publication date Aug 17, 2017
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDO INHIBITORS
- Publication number 20160289171
- Publication date Oct 6, 2016
- Bristol-Myers Squibb Company
- James Aaron Balog
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Srinivas Cheruku

Person

Patents Grantslast 30 patents

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Substituted amide compounds useful as farnesoid X receptor modulators

Substituted bicyclic compounds as farnesoid X receptor modulators

Substituted bicyclic compounds as farnesoid X receptor modulators

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Selective NR2B antagonists

Selective NR2B antagonists

Bridged bicyclic compounds as farnesoid X receptor modulators

Selective NR2B antagonists

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

Selective NR2B antagonists

IDO inhibitors

IDO inhibitors

Patents Applicationslast 30 patents

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SELECTIVE NR2B ANTAGONISTS

SELECTIVE NR2B ANTAGONISTS

INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE

BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SELECTIVE NR2B ANTAGONISTS

SELECTIVE NR2B ANTAGONISTS

INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER

IDO INHIBITORS

IDO INHIBITORS